408 related articles for article (PubMed ID: 33193107)
1. The Genetic Architecture of High Bone Mass.
Gregson CL; Duncan EL
Front Endocrinol (Lausanne); 2020; 11():595653. PubMed ID: 33193107
[TBL] [Abstract][Full Text] [Related]
2. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
[TBL] [Abstract][Full Text] [Related]
3. Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass Cases.
Gregson CL; Wheeler L; Hardcastle SA; Appleton LH; Addison KA; Brugmans M; Clark GR; Ward KA; Paggiosi M; Stone M; Thomas J; Agarwal R; Poole KE; McCloskey E; Fraser WD; Williams E; Bullock AN; Davey Smith G; Brown MA; Tobias JH; Duncan EL
J Bone Miner Res; 2016 Mar; 31(3):640-9. PubMed ID: 26348019
[TBL] [Abstract][Full Text] [Related]
4. 'Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass.
Gregson CL; Steel SA; O'Rourke KP; Allan K; Ayuk J; Bhalla A; Clunie G; Crabtree N; Fogelman I; Goodby A; Langman CM; Linton S; Marriott E; McCloskey E; Moss KE; Palferman T; Panthakalam S; Poole KE; Stone MD; Turton J; Wallis D; Warburton S; Wass J; Duncan EL; Brown MA; Davey-Smith G; Tobias JH
Osteoporos Int; 2012 Feb; 23(2):643-54. PubMed ID: 21455762
[TBL] [Abstract][Full Text] [Related]
5. A Rare Mutation in SMAD9 Associated With High Bone Mass Identifies the SMAD-Dependent BMP Signaling Pathway as a Potential Anabolic Target for Osteoporosis.
Gregson CL; Bergen DJM; Leo P; Sessions RB; Wheeler L; Hartley A; Youlten S; Croucher PI; McInerney-Leo AM; Fraser W; Tang JC; Anderson L; Marshall M; Sergot L; Paternoster L; Davey Smith G; ; Brown MA; Hammond C; Kemp JP; Tobias JH; Duncan EL
J Bone Miner Res; 2020 Jan; 35(1):92-105. PubMed ID: 31525280
[TBL] [Abstract][Full Text] [Related]
6. Rare and Common Variants in GALNT3 May Affect Bone Mass Independently of Phosphate Metabolism.
Hassan N; Gregson CL; Tang H; van der Kamp M; Leo P; McInerney-Leo AM; Zheng J; Brandi ML; Tang JCY; Fraser W; Stone MD; Grundberg E; ; Brown MA; Duncan EL; Tobias JH
J Bone Miner Res; 2023 May; 38(5):678-691. PubMed ID: 36824040
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study of extreme high bone mass: Contribution of common genetic variation to extreme BMD phenotypes and potential novel BMD-associated genes.
Gregson CL; Newell F; Leo PJ; Clark GR; Paternoster L; Marshall M; Forgetta V; Morris JA; Ge B; Bao X; Duncan Bassett JH; Williams GR; Youlten SE; Croucher PI; Davey Smith G; Evans DM; Kemp JP; Brown MA; Tobias JH; Duncan EL
Bone; 2018 Sep; 114():62-71. PubMed ID: 29883787
[TBL] [Abstract][Full Text] [Related]
8. Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations.
Gregson CL; Poole KE; McCloskey EV; Duncan EL; Rittweger J; Fraser WD; Smith GD; Tobias JH
J Clin Endocrinol Metab; 2014 Aug; 99(8):2897-907. PubMed ID: 24606091
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of high bone mass cases from the BARCOS cohort of Spanish postmenopausal women.
Sarrión P; Mellibovsky L; Urreizti R; Civit S; Cols N; García-Giralt N; Yoskovitz G; Aranguren A; Malouf J; Di Gregorio S; Río LD; Güerri R; Nogués X; Díez-Pérez A; Grinberg D; Balcells S
PLoS One; 2014; 9(4):e94607. PubMed ID: 24736728
[TBL] [Abstract][Full Text] [Related]
10. Genetic control of bone mass.
Boudin E; Fijalkowski I; Hendrickx G; Van Hul W
Mol Cell Endocrinol; 2016 Sep; 432():3-13. PubMed ID: 26747728
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2.
Butscheidt S; Delsmann A; Rolvien T; Barvencik F; Al-Bughaili M; Mundlos S; Schinke T; Amling M; Kornak U; Oheim R
Osteoporos Int; 2018 Jul; 29(7):1643-1651. PubMed ID: 29594386
[TBL] [Abstract][Full Text] [Related]
12. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.
Ren N; Lv S; Li X; Shao C; Wang Z; Mei Y; Yang W; Fu W; Hu Y; Sha L; Hu W; Zhang Z; Wang C
Osteoporos Int; 2024 Apr; ():. PubMed ID: 38625381
[TBL] [Abstract][Full Text] [Related]
13. Development of the Bone Phenotype and microRNA Profile in Adults With Low-Density Lipoprotein Receptor-Related Protein 5-High Bone Mass (LRP5-HBM) Disease.
Lauterlein JL; Gossiel F; Weigl M; Eastell R; Hackl M; Hermann P; Bollerslev J; Frost M
JBMR Plus; 2021 Sep; 5(9):e10534. PubMed ID: 34532618
[TBL] [Abstract][Full Text] [Related]
14. Common and rare variants of WNT16, DKK1 and SOST and their relationship with bone mineral density.
Martínez-Gil N; Roca-Ayats N; Monistrol-Mula A; García-Giralt N; Díez-Pérez A; Nogués X; Mellibovsky L; Grinberg D; Balcells S
Sci Rep; 2018 Jul; 8(1):10951. PubMed ID: 30026596
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of DXA and HR-pQCT in Autosomal Dominant Osteopetrosis (ADO II).
Butscheidt S; Rolvien T; Kornak U; Schmidt FN; Schinke T; Amling M; Oheim R
Calcif Tissue Int; 2018 Jan; 102(1):41-52. PubMed ID: 29018903
[TBL] [Abstract][Full Text] [Related]
16. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5.
Frost M; Andersen T; Gossiel F; Hansen S; Bollerslev J; van Hul W; Eastell R; Kassem M; Brixen K
J Bone Miner Res; 2011 Aug; 26(8):1721-8. PubMed ID: 21351148
[TBL] [Abstract][Full Text] [Related]
17. The Polygenic and Monogenic Basis of Paediatric Fractures.
Ghatan S; Costantini A; Li R; De Bruin C; Appelman-Dijkstra NM; Winter EM; Oei L; Medina-Gomez C
Curr Osteoporos Rep; 2021 Oct; 19(5):481-493. PubMed ID: 33945105
[TBL] [Abstract][Full Text] [Related]
18. Identification of Rare
Rocca MS; Minervini G; Di Nisio A; Merico M; Bueno Marinas M; De Toni L; Pilichou K; Garolla A; Foresta C; Ferlin A
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639175
[TBL] [Abstract][Full Text] [Related]
19. Quantitative trait loci affecting peak bone mineral density in mice.
Klein RF; Mitchell SR; Phillips TJ; Belknap JK; Orwoll ES
J Bone Miner Res; 1998 Nov; 13(11):1648-56. PubMed ID: 9797472
[TBL] [Abstract][Full Text] [Related]
20. Clinical review: Genome-wide association studies of skeletal phenotypes: what we have learned and where we are headed.
Hsu YH; Kiel DP
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1958-77. PubMed ID: 22965941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
